ATE22557T1 - Bicyclo(4.2.0)oktatriene-1,3,5 derivate, verfahren zu deren herstellung und deren therapeutische anwendung. - Google Patents

Bicyclo(4.2.0)oktatriene-1,3,5 derivate, verfahren zu deren herstellung und deren therapeutische anwendung.

Info

Publication number
ATE22557T1
ATE22557T1 AT84400056T AT84400056T ATE22557T1 AT E22557 T1 ATE22557 T1 AT E22557T1 AT 84400056 T AT84400056 T AT 84400056T AT 84400056 T AT84400056 T AT 84400056T AT E22557 T1 ATE22557 T1 AT E22557T1
Authority
AT
Austria
Prior art keywords
octatriene
bicyclo
derivatives
production
therapeutic application
Prior art date
Application number
AT84400056T
Other languages
English (en)
Inventor
Charles Malen
Jean-Louis Peglion
Michel Laubie
Jean-Claude Poignant
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of ATE22557T1 publication Critical patent/ATE22557T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
AT84400056T 1983-01-14 1984-01-12 Bicyclo(4.2.0)oktatriene-1,3,5 derivate, verfahren zu deren herstellung und deren therapeutische anwendung. ATE22557T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8300502A FR2539415B1 (fr) 1983-01-14 1983-01-14 Derives de la d-2 imidazoline, leur preparation et leur application en therapeutique
EP84400056A EP0119107B1 (de) 1983-01-14 1984-01-12 Bicyclo(4.2.0)oktatriene-1,3,5 Derivate, Verfahren zu deren Herstellung und deren therapeutische Anwendung

Publications (1)

Publication Number Publication Date
ATE22557T1 true ATE22557T1 (de) 1986-10-15

Family

ID=9284924

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84400056T ATE22557T1 (de) 1983-01-14 1984-01-12 Bicyclo(4.2.0)oktatriene-1,3,5 derivate, verfahren zu deren herstellung und deren therapeutische anwendung.

Country Status (17)

Country Link
US (1) US4567181A (de)
EP (1) EP0119107B1 (de)
JP (1) JPS59139361A (de)
AT (1) ATE22557T1 (de)
AU (1) AU562182B2 (de)
CA (1) CA1212111A (de)
DE (1) DE3460834D1 (de)
DK (1) DK12584A (de)
ES (1) ES8503681A1 (de)
FR (1) FR2539415B1 (de)
GR (1) GR79170B (de)
IL (1) IL70684A (de)
NO (1) NO159379C (de)
NZ (1) NZ206833A (de)
OA (1) OA07633A (de)
PT (1) PT77961B (de)
ZA (1) ZA84261B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166937B1 (de) * 1984-06-06 1991-08-28 Abbott Laboratories Adrenergische Verbindungen
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
US4923444A (en) * 1988-12-19 1990-05-08 Ivac Corporation Negative pressure measurement system
CA1321751C (en) * 1989-02-21 1993-08-31 Eugene C. Crichlow Mechanism mediating ruminal stasis in ruminal lactic acidosis
JP3761960B2 (ja) * 1996-03-19 2006-03-29 仁美 鈴木 ガス中の二酸化炭素の除去方法
FR2935381B1 (fr) * 2008-08-29 2010-12-17 Servier Lab Nouveau procede de resolution des enantiomerees du (3,4-dimethoxy-bicyclo°4.2.0!octa-1,3,5-trien-7-yl)nitrile et application a la synthese de l'ivabradine
US9562136B2 (en) 2011-07-04 2017-02-07 Cambridge Display Technology, Ltd. Polymers, monomers and methods of forming polymers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE551610A (de) * 1955-10-13 1900-01-01
US3287469A (en) * 1963-09-27 1966-11-22 Du Pont Naphthyl-and indanylimidazolines
US3927023A (en) * 1974-05-24 1975-12-16 Warner Lambert Co Imidazolyl benzofurans
US4226876A (en) * 1976-12-20 1980-10-07 Burroughs Wellcome Co. Arthropodicidal imidazoline derivatives
DE2933962A1 (de) * 1979-08-22 1981-03-26 Hoechst Ag, 65929 Frankfurt Verfahren zur herstellung von 4,5-dichlor-imidazolen.
NZ201219A (en) * 1981-07-28 1984-10-19 Reckitt & Colmann Prod Ltd Dihydrobenzofuranyl-2-imidazolines and pharmaceutical compositions

Also Published As

Publication number Publication date
AU562182B2 (en) 1987-06-04
IL70684A0 (en) 1984-04-30
GR79170B (de) 1984-10-02
ES528877A0 (es) 1985-03-01
PT77961A (fr) 1984-02-01
NO159379B (no) 1988-09-12
EP0119107A1 (de) 1984-09-19
ZA84261B (en) 1984-08-29
DK12584A (da) 1984-07-15
JPS59139361A (ja) 1984-08-10
FR2539415B1 (fr) 1985-09-13
EP0119107B1 (de) 1986-10-01
NO840131L (no) 1984-07-16
DK12584D0 (da) 1984-01-12
IL70684A (en) 1987-07-31
NZ206833A (en) 1987-02-20
PT77961B (fr) 1986-06-18
NO159379C (no) 1988-12-21
ES8503681A1 (es) 1985-03-01
US4567181A (en) 1986-01-28
JPS632957B2 (de) 1988-01-21
FR2539415A1 (fr) 1984-07-20
AU2327784A (en) 1984-07-19
DE3460834D1 (en) 1986-11-06
OA07633A (fr) 1985-05-23
CA1212111A (fr) 1986-09-30

Similar Documents

Publication Publication Date Title
LU91587I2 (fr) Agomélatine et ses dérivés pharmaceutiquement acceptables (VALDOXAN)
NO162518C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive 8-klor-1,5-benzothiazepinderivater.
ES510649A0 (es) "procedimiento para la preparacion de 9-(2-(3-indolil)-etil)-1-oxa-4,9-diazaspiro (5.5) undecan-3-onas".
NO883994L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinylaminer.
DE3483798D1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate.
ATE22557T1 (de) Bicyclo(4.2.0)oktatriene-1,3,5 derivate, verfahren zu deren herstellung und deren therapeutische anwendung.
ATE37533T1 (de) Derivate der 4-phenyl-4-oxo-buten-2-saeure, verfahren zu ihrer herstellung, medikamente und mischungen mit diesen derivaten.
PT77666B (fr) Procede de preparation de nouveaux derives de la nitrosouree
SE8005686L (sv) Nya halogenvinkamonderivat jemte sett for deras framstellning
NO167029C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinkarboksylsyrederivater
ES2037783T3 (es) Procedimiento para la obtencion de 3-aminosidnoniminas substituidas.
SE8005687L (sv) Nya 10-halogen-e-homoeburnaner jemte sett for deras framstellning
SE8803765D0 (sv) Nya isopolypeptider samt foerfarande foer framstaellning av desamma
PT92494A (pt) Processo para a preparacao de novos derivados do indol
IT1204494B (it) Derivati della 1-stirene solfonil 2-osso 5-alcossi pirrolidina,loro procedimento di preparazione e loro applicazione come farmaci
SE8400629L (sv) Basiska oximetrar
IT1191109B (it) Derivati di acidi aminopiridincarbossilici,loro metodo di sintesi e composizioni farmaceutiche che li contengono
NO159271C (no) Analogifremgangsmaate for fremstiling av terapeutisk aktive substituerte isokinolinderivater.
SE7901707L (sv) 2-betoxibensamider
ES536139A0 (es) Procedimiento para la preparacion de quinolinonas-4
ES501744A0 (es) Procedimiento para la obtencion de bis (fenoxiacetatos sus- tituidos)de n-alcohil-dialcanolaminas
AT383599B (de) Verfahren zur herstellung von neuen racemischen und optisch aktiven e-homo-eburnan-derivaten sowievon saeureadditions-salzen derselben
ES2089439T3 (es) Nuevos derivados amidicos de 1-amino-octahidro-pirido-(2,1-c)-(1,4)-oxazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE58375T1 (de) Dibenzo(be>oxepinessigsaeure-derivate, deren herstellung und therapeutische verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee